Broutin et al. investigated the dependence of MEK and mTOR inhibition in a panel of KRAS mutant and KRAS wildtype NSCLC cell lines and showed for the first time that inhibition of mTOR but not MEK contributes to the majority of the growth inhibition in this combination [122]. This evidence concerns the gene MAP2K7 and non-small cell lung carcinoma.